Charalampos Siotos, Michelle Y Seu, Reilly Frauchiger-Ankers, Lauren E Delmastro, Cristina O'Donoghue, Andrea Madrigrano, Rosalinda Alvarado, Claudia B Perez, Keith C Hood, Deana S Shenaq, George Kokosis, David E Kurlander
This study evaluated trends in Medicare reimbursement for commonly performed breast oncologic and reconstructive procedures. Average national relative value units (RVUs) for physician-based work, facilities, and malpractice were collected along with the corresponding conversion factors for each year. From 2010 to 2021, there was an overall average decrease of 15% in Medicare reimbursement for both breast oncology (-11%) and reconstructive procedures (-16%). Based on these findings, breast and reconstructive surgeons should advocate for reimbursement that better reflects the costs of their practice...
May 4, 2024: Journal of Plastic, Reconstructive & Aesthetic Surgery: JPRAS